期刊
PHYSICAL CHEMISTRY CHEMICAL PHYSICS
卷 25, 期 30, 页码 20597-20605出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d3cp01723k
关键词
-
Nafamostat and camostat inhibit the fusion of SARS-CoV-2 by forming a covalent bond with TMPRSS2. Nafamostat exhibits stronger inhibitory activity compared to camostat, and the molecular mechanism of TMPRSS2 inhibition remains unclear.
Nafamostat and camostat are known to inhibit the spike protein-mediated fusion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by forming a covalent bond with the human transmembrane serine protease 2 (TMPRSS2) enzyme. Previous experiments revealed that the TMPRSS2 inhibitory activity of nafamostat surpasses that of camostat, despite their structural similarities; however, the molecular mechanism of TMPRSS2 inhibition remains elusive. Herein, we report the energy profiles of the acylation reactions of nafamostat, camostat, and a nafamostat derivative by quantum chemical calculations using a combined molecular cluster and polarizable continuum model (PCM) approach. We further discuss the physicochemical relevance of their inhibitory activity in terms of thermodynamics and kinetics. Our analysis attributes the strong inhibitory activity of nafamostat to the formation of a stable acyl intermediate and its low activation energy during acylation with TMPRSS2. The proposed approach is also promising for elucidating the molecular mechanisms of other covalent drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据